amikin 100 mg/2ml solution for injection
bristol-myers squibb (holdings) limited - amikacin sulfate - solution for injection - 100 mg/2ml - other aminoglycosides
adcortyl intra-articular / intradermal 10mg/1ml suspension for injection ampoules
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 10mg/1ml
kenalog intra-articular / intramuscular 40mg/1ml suspension for injection vials
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 40mg/1ml
adcortyl intra-articular / intradermal 50mg/5ml suspension for injection vials
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 10mg/1ml
kenalog intramuscular 80mg/2ml suspension for injection pre-filled syringes
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 40mg/1ml
kenalog intramuscular 40mg/1ml suspension for injection pre-filled syringes
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 40mg/1ml
azactam 1g powder for solution for injection vials
bristol-myers squibb pharmaceuticals ltd - aztreonam - powder for solution for injection - 1gram
azactam 2g powder for solution for injection vials
bristol-myers squibb pharmaceuticals ltd - aztreonam - powder for solution for injection - 2gram
onureg 200 mg
bristol, myers squibb (israel) limited, israel - azacitidine - film coated tablets - azacitidine 200 mg - azacitidine - onureg is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (cr) or complete remission with incomplete blood count recovery (cri) following intensive induction chemotherapy and are not able to complete intensive curative therapy
onureg 300 mg
bristol, myers squibb (israel) limited, israel - azacitidine - film coated tablets - azacitidine 300 mg - azacitidine - onureg is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (cr) or complete remission with incomplete blood count recovery (cri) following intensive induction chemotherapy and are not able to complete intensive curative therapy